Published in Gene Therapy Weekly, January 9th, 2003
"Kallistatin is a unique serine proteinase inhibitor (serpin) and a heparin-binding protein. It has been localized in vascular smooth muscle cells and endothelial cells of human blood vessels, suggesting that kallistatin may be involved in the regulation of vascular function," wrote R.Q. Miao and colleagues, who previously demonstrated "that kallistatin plays a role in neointima hyperplasia."
In their current study, published in the journal Blood, Miao's group "investigated the potential role of kallistatin in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.